SCHEMBL510598

SCHEMBL510598

Cc1cccc(CCl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29502747 1.00
Hydrochloric Acid SCHEMBL114052 0.98 CCR1 (0.46)
Hydrochloric Acid SCHEMBL3582594 0.96 CCR1 (0.44)
SCHEMBL10894853 0.87 CCR1 (0.64)
SCHEMBL10974261 0.82 SMN1; SMN2 (0.45)
SCHEMBL734728 0.82 KCNH2 (0.44)
Hydrochloric Acid SCHEMBL5728429 0.80 SMN1; SMN2 (0.47)
SCHEMBL24916774 0.80 CCR1 (0.52)
SCHEMBL14082023 0.80 CCR1 (0.52)
SCHEMBL30201993 0.80 CCR1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118772047-A Preparation method of 2, 6-dichloropyridine 江苏宝东医药科技有限公司 2024-10-15 CN claimed
CN-117229654-A Modified graphene oxide, modified graphene oxide/vinyl ester resin, and preparation methods and applications thereof 华南农业大学 2023-12-15 CN claimed
JP-55089265-A None JP disclosed
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 US disclosed
US-20260008784-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES VASTHERA CO LTD (KR) 2026-01-08 US disclosed
EP-4547673-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES VASTHERA Co. Ltd. (KR) 2025-05-07 EP disclosed
CN-119403810-A Compounds, pharmaceutical compositions containing them and their medical use for the treatment or prevention of vascular diseases 瓦斯塞拉股份有限公司 2025-02-07 CN disclosed
WO-2025016200-A1 CHELATING RESIN COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF 上海稀固科技有限公司 2025-01-23 WO disclosed
CN-119331129-A Chelate resin composition, preparation method and application thereof 上海稀固科技有限公司 2025-01-21 CN disclosed
CN-119192183-A Benzodiazepines class of compounds and uses thereof 中国药科大学 2024-12-27 CN disclosed
US-12144816-B2 Substituted indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2024-11-19 US disclosed
EP-0150984-A2 6-(Substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof PFIZER INC. (US) 1985-08-07 EP disclosed
US-4511720-A HYPOTENSIVE AGENTS HOFFMANN-LA ROCHE INC. (US) 1985-04-16 US disclosed
EP-0113587-A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them Richter Gedeon Vegyészeti Gyár R.T. (HU) 1984-07-18 EP disclosed
US-4355033-A TREATMENT OF HYPERTENSION HOFFMAN-LA ROCHE INC. (US) 1982-10-19 US disclosed
EP-0002010-B1 DERIVATIVES OF 2-IMINO-IMIDAZOLIDINE, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-07-14 EP disclosed
US-4244957-A HYPOTENSIVE AGENTS HOFFMAN-LA ROCHE INC. (US) 1981-01-13 US disclosed
JP-S5589265-A PREPARATION OF 2,6-BIS(CHLOROMETHYL)PYRIDINE SEITETSU KAGAKU CO LTD 1980-07-05 JP disclosed
EP-0002010-A1 Derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-05-30 EP disclosed
US-3969526-A Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles SMITHKLINE CORPORATION (US) 1976-07-13 US disclosed